SCHEMBL6824979

SCHEMBL6824979

Cc1ccccc1C(=O)c1ccc(Nc2ccccc2NC(=O)Nc2ccccc2)cc1Cl

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 14/20 0.77
MAPK13 O15264 12/20 0.77
MAPK12 P53778 12/20 0.77
MAPK11 Q15759 12/20 0.77
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
MAPT P10636 3/20 0.51
KDM4E B2RXH2 2/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 1/20 0.50
NFKB1 P19838 1/20 0.50
GFER P55789 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651799 0.91 MAPK14 (0.84) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL6824435 0.90 MAPK14 (0.79) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7642695 0.87 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL6827035 0.87 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GAA
SCHEMBL6824404 0.87 MAPK14 (0.74) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL6824421 0.87 MAPK14 (0.74) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1904637 0.85 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11
SCHEMBL6824447 0.85 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11LMNA
SCHEMBL6821196 0.85 MAPK14 (0.84) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1905352 0.84 MAPK14 (0.83) MAPK14MAPK13MAPK12MAPK11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP claimed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US claimed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP claimed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO claimed
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP disclosed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US disclosed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP disclosed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO disclosed